Early Response to Certolizumab Pegol in Rheumatoid Arthritis Predicts Outcome at One Year
Nov 1, 2013, 00:00 AM
10.1016/j.jval.2013.08.1452
https://www.valueinhealthjournal.com/article/S1098-3015(13)03357-3/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1296
First Page :
A556
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)03357-3&doi=10.1016/j.jval.2013.08.1452